Androgens in breast cancer. III. Breast cancer recurrences years after mastectomy and increased androgenic activity.
To test the hypothesis that increased androgenic activity is involved in breast cancer, the urinary testosterone was assayed in 19 clinically cured breast cancer patients and in 22 patients developing metastases from breast cancer during the same period of observation (5 to 15 years after mastectomy). The levels in the clinically cured patients were near normal whereas those in patients with metastases were significantly above normal.
D000367:Age Factors; D000368:Aged; D000728:Androgens / Q000378:metabolism* / Q000652:urine; D001943:Breast Neoplasms / Q000150:complications / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control* / Q000601:surgery / Q000652:urine; D002369:Castration; D004714:Endometrial Hyperplasia / Q000209:etiology / Q000473:pathology; D005260:Female; D006801:Humans; D008408:Mastectomy; D008593:Menopause; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D010051:Ovarian Neoplasms / Q000209:etiology / Q000601:surgery; D010053:Ovary / Q000473:pathology / Q000503:physiopathology; D013739:Testosterone / Q000652:urine; D013997:Time Factors
D000728:Androgens; D013739:Testosterone